Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Perrigo Co's yield on cost for the quarter that ended in Jun. 2026 was 0.00.
The historical rank and industry rank for Perrigo Co's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Perrigo Co's highest Yield on Cost was 16.08. The lowest was 0.55. And the median was 2.76.
MEX:PRGON's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.29 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Perrigo Co (MEX:PRGON) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Perrigo Co 5-Year Yield-on-Cost % Related Terms
MEX:PRGON vs PAHC, HROW, XERS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Perrigo Co's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Perrigo Co is calculated as
Perrigo Co (MEX:PRGON) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Perrigo Co and its competitors. Over the past decade, Perrigo Co's 5-Year Yield-on-Cost % has ranged from 0.55 to 16.08. According to the industry distribution chart, Perrigo Co ranks #47 out of 513 companies in the Drug Manufacturers industry, placing it in the top 9.2%.
Is Perrigo Co's 5-Year Yield-on-Cost % too high?
Perrigo Co's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.55 to a high of 16.08. Based on the distribution chart, Perrigo Co ranks #47 out of 513 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Perrigo Co has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Perrigo Co's 5-Year Yield-on-Cost % compare to PAHC and HROW?
According to the Drug Manufacturers industry distribution chart, Perrigo Co ranks #47 out of 513 companies for 5-Year Yield-on-Cost %. This places Perrigo Co in the top 9% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.29. Historically, Perrigo Co's own 5-Year Yield-on-Cost % has ranged from 0.55 to 16.08 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.29, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Perrigo Co and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perrigo Co's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perrigo Co stock overvalued right now?
Perrigo Co (MEX:PRGON) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is MXN1,039.05, compared to a current price of MXN557.52 — trading 46.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Perrigo Co's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Perrigo Co (MEX:PRGON), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Perrigo Co (MEX:PRGON) Overvalued in 2026?
Based on GuruFocus' analysis, Perrigo Co stock appears to be undervalued.
The current stock price of MXN557.52 is trading 46.3% below its estimated GF Value™ of MXN1,039.05.
Key valuation signals for MEX:PRGON:
5-Year Yield-on-Cost %: 0.00
GF Value™: MXN1,039.05 vs. price of MXN557.52 (46.3% below fair value)
No single metric tells the full story. See the MEX:PRGON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
49GF Score
Get the complete analysis for MEX:PRGON
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PRGON has been successfully added to your 
